C-MER Eye Care Holdings Limited (HK:3309) has released an update.
C-MER Eye Care Holdings Limited has announced plans to allocate up to HK$100 million for a share repurchase program over the next 12 months, reflecting the Board’s and executive director Dr. Lam’s confidence in the company’s future. The repurchases are subject to market conditions and the Board’s discretion, and investors are cautioned to be mindful of the non-guaranteed nature of this buyback when trading shares.
For further insights into HK:3309 stock, check out TipRanks’ Stock Analysis page.
